Literature DB >> 10631474

Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody Trastuzumab.

C Kollmannsberger, H Pressler, F Mayer, L Kanz, C Bokemeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10631474     DOI： 10.1023/a:1008365216323

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  [Targeted therapy of urological tumours. Experimental field or established therapeutic approach?].

Authors:  M W Kramer; S Krege; I Peters; A S Merseburger; M A Kuczyk
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

2.  Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.

Authors:  Dimitrios Tsapralis; Ioannis Panayiotides; George Peros; Theodore Liakakos; Eva Karamitopoulou
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 3.  Emerging Therapeutic Targets for Male Germ Cell Tumors.

Authors:  Christian Daniel Fankhauser; Friedemann Honecker; Jörg Beyer; Peter Karl Bode
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

4.  Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.

Authors:  Ryan Ashkar; Darren R Feldman; Nabil Adra; Mohammad Abu Zaid; Samuel A Funt; Sandra K Althouse; Susan M Perkins; Christin I Snow; Kayla M Lazzara; Lina M Sego; David I Quinn; Nasser H Hanna; Lawrence H Einhorn; Costantine Albany
Journal:  Invest New Drugs       Date:  2021-05-24       Impact factor: 3.651

5.  IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.

Authors:  Joanna Selfe; Neil C Goddard; Alan McIntyre; Kathryn R Taylor; Jane Renshaw; Sergey D Popov; Khin Thway; Brenda Summersgill; Robert A Huddart; Duncan C Gilbert; Janet M Shipley
Journal:  J Pathol       Date:  2018-01-10       Impact factor: 7.996

6.  Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

Authors:  Stephanie J Gros; Nina Kurschat; Astrid Drenckhan; Thorsten Dohrmann; Evelyn Forberich; Katharina Effenberger; Uta Reichelt; Robert M Hoffman; Klaus Pantel; Jussuf T Kaifi; Jakob R Izbicki
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.